Showing results (1-10 of 394) with videos related to
Sort By:
Pageof 40
Leukemia|August 29, 2019
Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript typeMichele Baccarani, Gianantonio Rosti, Simona SoveriniAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Molecular monitoring and mutations in chronic myeloid leukemia: how to get the most out of your tyrosine kinase inhibitorMichele Baccarani, Simona Soverini, Caterina De BenedittisExpert Review of Anticancer Therapy|June 7, 2008
Imatinib mesylate for the treatment of chronic myeloid leukemiaSimona Soverini, Giovanni Martinelli, Ilaria Iacobucci, et al.Current Hematologic Malignancy Reports|January 8, 2014
Molecular monitoringSimona Soverini, Gianantonio Rosti, Michele Baccarani, et al.Nature Clinical Practice. Oncology|December 19, 2008
Intermittent targeting as a tool to minimize toxicity of tyrosine kinase inhibitor therapyGiovanni Martinelli, Simona Soverini, Ilaria Iacobucci, et al.The Oncologist|June 3, 2011
Choosing the best second-line tyrosine kinase inhibitor in imatinib-resistant chronic myeloid leukemia patients harboring Bcr-Abl kinase domain mutations: how reliable is the IC₅₀?Simona Soverini, Gianantonio Rosti, Ilaria Iacobucci, et al.Pharmacogenomics|August 28, 2012
Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr-Abl mutations and mutational analysisSimona Soverini, Giovanni Martinelli, Gianantonio Rosti, et al.Haematologica|April 12, 2005
New tyrosine kinase inhibitors in chronic myeloid leukemiaGiovanni Martinelli, Simona Soverini, Gianantonio Rosti, et al.Best Practice & Research. Clinical Haematology|December 5, 2009
Response definitions and European Leukemianet Management recommendationsMichele Baccarani, Fausto Castagnetti, Gabriele Gugliotta, et al.Journal of Clinical Medicine|June 6, 2020
Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and PerspectivesDomenico Russo, José Valentín Garcia-Gutierrez, Simona Soverini, et al.Pageof 40